WHO ICTRP trial
The efficacy of low-frequency ultrasonic debridement (LFUD) and…
ACTRN12617001291370 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12617001291370 |
|---|---|
| Public title | The efficacy of low-frequency ultrasonic debridement (LFUD) and Polyhexamethylene Biguanide (PHMB) combination therapy for adults with chronic wounds; a randomised controlled trial |
| Scientific title | The efficacy of low-frequency ultrasonic debridement (LFUD) and Polyhexamethylene Biguanide (PHMB) combination therapy for adults with chronic wounds; a randomised controlled trial |
| Primary sponsor | Marianne Wallis |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia |
| Conditions | Chronic wounds; Chronic wounds;Infection - Studies of infection and infectious agents;Skin - Other skin conditions |
| Interventions | Each participant will receive ultrasonic debridement on their wound weekly for six weeks in a specified specialist wound clinic in the University Health Clinics. The ultrasonic procedure involves the use of a low-frequency ultrasound… |
| Registration date | Jun 9, 2017 |
| Target size | 50 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: